News & Events : Events : Evolving Regulatory expectation for Particulates in Biologics
April 29, 2010
This webinar addresses evolving regulatory requirements for particulates and the techniques suitable for testing and characterizing sub-visible particulates in therapeutic formulations. Why Should You Attend: Particulate analysis in Protein Therapeutics has received increasing regulatory attention due to the correlation of aggregates and particles in protein therapeutics with immunogenicity. Recent FDA-Industry meetings have focused on the need for analysis of particulates smaller than the size range measured by the USP Light Obscuration test and the instrumentation available to perform such testing. This webinar will discuss the current regulatory requirements for testing protein therapeutics for particulates, followed by a discussion of various available methods including the simplest QC friendly techniques such as SDS-PAGE to characterization methods such as Analytical Ultracentrifugation, Field Flow Fractionation and Laser Diffraction. The instrumentation available, the advantages and disadvantages of these methods will be discussed. For more information, contact:Admin
2600 E. Bayshore Road Palo Alto, CA 94303
650-620-3915
650-963-2556
http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=701600?channel=nhbio